Company · CIK 0001829635 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Transcode Therapeutics, Inc. · RNAZ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 CForm 4 → | Aug 5, 4:05 pm EDT | DEFJ, LLC +110% Owner | 13,834,441 | — | — | 14,134,481 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 AForm 4 → | Sep 11, 5:10 pm EDT | Thomas A FitzgeraldChief Financial Officer, Director | 185,000 | — | — | 185,000 | — | |
| Aug 3, 2026 CForm 4 → | Aug 5, 4:05 pm EDT | DEFJ, LLC +110% Owner | 1,383 | — | — | 0 | — |